Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 28, 2026CVIR OncologyOpen Access

Hepatocellular carcinoma patients treated with TARE monotherapy or combination therapy with curative intent: a retrospective, exploratory analysis of two European prospective studies

View Full Paper
Ask AI
Bookmark
Share

Authors

THT HelmbergerMünchen Klinik BogenhausenDAD. ArnoldAsklepios Klinik AltonaRLR. LoffroyCHU Dijon Bourgogne

Discussion

Loading...

Member takes

Implication

Retrospective analysis identifies treatment outcomes of TARE in hepatocellular carcinoma, suggesting its curative potential.

Key Points

  • The analysis aims to explore the effectiveness and treatment strategies of TARE for hepatocellular carcinoma with curative intent.
  • Combined analysis of 615 patients treated with TARE from 2015 to 2020.
  • Data collected on baseline characteristics, treatment intent, and follow-up.
  • Patients classified into curative and palliative intent groups based on treatment goals.
  • Majority of patients (93%) received TARE with palliative intent, contrary to initial assessments.
  • In the curative-intent group, 50% underwent transplantation and 17.5% received ablation.
  • Factors associated with curative allocation included ECOG performance status and tumor volume < 150 cc.

Cite This Study

Helmberger et al. (2026) studied this question.

synapsesocial.com/papers/69c7724e8bbfbc51511e2b42https://doi.org/10.1007/s44343-026-00035-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis1996 · 7,227 citations
  2. 2Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries2021 · 114,850 citations
  3. 3Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study2022 · 90 citations
  4. 4Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience2023 · 25 citations
  5. 5Liver Transplantation for Advanced Hepatocellular Carcinoma Using Poor Tumor Differentiation on Biopsy as an Exclusion Criterion2010 · 286 citations